Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Have HIV
Safety and immunogenicity Phase II study in 200 pregnant women in South Africa and Uganda. Study supported by European Developing Countries Trial Partnership.
Study has completed enrolment and is ongoing
South Africa and Uganda